Had a bit of a look around over the weekend with various different google questions, just a summary of sorts....
1... there are still many questions by various oncology groups concerning whether the lag-3 gene research at this point has shown enough in trials to be confirmed as a success... 2... concerns it's compatibility and effectiveness in combos with pd1-L1 inhibitors hasn't been proven yet, more information needed...
it seems the market needs more convincing which would explain latest trading patterns, I suspect we need large (n) trial numbers that come back positive to see a decent market reaction that is sustainable...
IMM Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)